Home
Services
Portfolio
Jobs
News
Search
Services
Portfolio
People
Jobs
News
Recent News
P95 held its annual retreat in Mallorca
2 November 2022
At the beginning of October, we held our Annual Retreat in beautiful Mallorca. Around 100 employees were present! This was […]
[…]
Read more…
A tour of our new P95 Latina office
2 November 2022
We’re excited to share a quick tour of our new P95 Latina office in Bogotá, Colombia, which opened in August […]
[…]
Read more…
P95 presents 5 posters at the International Conference on Lyme Borreliosis 2022
2 November 2022
The P95 Lyme Team (Leah Burn, MPH, Jehidys Montiel Ramos, Aura Victoria Gutiérrez Rabá, Thao Mai Phuong Tran) presented 5 posters at the International […]
[…]
Read more…
P95 featured in the GIZ’s 2021 Integrated Company Report
2 November 2022
The Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ) GmbH‘s 2021 Integrated Company Report highlights the international training program to enhance vaccine pharmacovigilance capacity […]
[…]
Read more…
DRIVE project comes to an end
11 July 2022
After five years, the Development of Robust and Innovative Effectiveness (DRIVE) project has come to an end. Set up in July […]
[…]
Read more…
P95 celebrates its 11th birthday
29 June 2022
On June 16h, 2022, P95 turned 11 years old! To everyone who has allowed our company to achieve this milestone, […]
[…]
Read more…
P95 Latina team meets in Bogota
29 June 2022
On the week of May 16th to May 20th, some of the Epidemiology and Medical Writing team leads met the […]
[…]
Read more…
“We saw in Latin America a hub of talented professionals in epidemiology and research”
28 June 2022
In this new interview, Adriana Bastidas, Regional Medical Director, and Blanca Escobar, Regional Head of Operations, talk about the creation of P95 Latina, the first branch […]
[…]
Read more…
“I want people to know that P95 has an important role in the improvement of public health worldwide”
28 June 2022
In this interview, Thomas Verstraeten, CEO of P95, speaks about company growth, visibility and entrepreneurship, as a comment to P95’s […]
[…]
Read more…
COVIDRIVE welcomes three new vaccine companies to the consortium
9 February 2022
08/02/2022 – Three new vaccine companies (Moderna, Novavax and Valneva) have joined the COVIDRIVE consortium and officially become COVIDRIVE partners. Moderna, Novavax and Valneva will further contribute to the assessment of the effectiveness of COVID-19 vaccines in Europe to support the region’s public health response and address the vaccine companies’ regulatory obligations. With the inclusion of these three newcomers, COVIDRIVE, which brings together public institutions, small and medium-sized enterprises and vaccine companies, has a total of 11 partners.
[…]
Read more…
P95 nominated for the Trends Gazelles Flemish Brabant 2022
24 November 2021
P95 is one of the nominees for the 2022 edition of Trends Gazelles Flemish Brabant. Trends Gazelles award aims to distinguish the fastest-growing Belgian companies over the past 5 years.
[…]
Read more…
P95 appoints Henk Hoornaert as Chief Commercial Officer
16 November 2021
P95 has appointed Henk Hoornaert as Chief Commercial Officer (CCO). After two years of accelerated growth, this appointment will strengthen P95’s structure and improve business development, marking a further step towards a more stable and mature organization.
[…]
Read more…
Largest ever Lassa fever study expands to more countries in West Africa
28 July 2021
July 28 2021, Oslo Norway, Cotonou Benin, Conakry Guinea, Monrovia Liberia, Abuja Nigeria, and Kenema Sierra Leone – The largest ever study created and funded by the Coalition for Epidemic Preparedness Innovations (CEPI) to provide a more accurate assessment of the incidence of Lassa fever infections has launched in several more countries in West Africa.
[…]
Read more…
The COVIDRIVE project has been officially launched
22 July 2021
A new public-private partnership – COVIDRIVE – announced today that it will begin studies to assess the effectiveness of multiple […]
[…]
Read more…
P95, Leuven-based company specialized in epidemiology and pharmacovigilance, acquires Rotterdam-based Pallas health research and consultancy (Pallas).
13 April 2021
Thomas Verstraeten, CEO of P95: Thanks to our extensive expertise in the development and implementation of vaccines, we experienced a […]
[…]
Read more…
P95 appoints Stefaan as Chief Financial Officer
8 July 2020
Services Portfolio People Jobs News P95 appoints Stefaan as Chief Financial Officer P95, a service provider specialized in epidemiology, statistics […]
[…]
Read more…
ECCMID 2018 – DRIVE is searching for new collaborators
19 April 2018
ECCMID in Madrid 21 April
[…]
Read more…
The incidence of medically-attended norovirus gastro-enteritis in Japan: Modelling using a medical care insurance claims database
3 April 2018
P95 co-authored paper on Norovirus disease in Japan featured in PLoS Disease Forecasting & Surveillance Channel
[…]
Read more…
Methodology for computing the burden of disease of adverse events following immunization
28 March 2018
Paper of P95 co-authors has been published online
[…]
Read more…
Overcoming barriers in HPV vaccination and screening programs
9 November 2017
Paper of P95 co-author has been published online
[…]
Read more…
Association between visual function response and reduction of inflammation in noninfectious Uveitis of the posterior segment
9 November 2017
Paper of P95 co-author has been published online
[…]
Read more…
A systematic review of varicella seroprevalence in European countries before universal childhood immunization deriving incidence from seroprevalence data
11 September 2017
Paper of P95 co-author has been published online
[…]
Read more…
Estimating the burden of medically-attended norovirus gastroenteritis: modelling linked primary care and hospitalization datasets
18 August 2017
Paper of P95 co-authors has been published online.
[…]
Read more…
Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic literature review and meta-analyses of observational studies
13 June 2017
Paper of P95 co-author has been published online.
[…]
Read more…
Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization
13 June 2017
Paper of P95 co-author has been published online.
[…]
Read more…
Background rates of disease in Latin American children from a Rotavirus vaccine study
13 June 2017
Paper of P95 co-author has been published online.
[…]
Read more…
P95 in Beijing
1 June 2017
P95 delivers a Pharmacovigilance Course to Asian vaccine manufacturers
[…]
Read more…
Norovirus in Latin America: Systematic Review and Meta-analysis
31 January 2017
Paper of P95 co-author has been published online.
[…]
Read more…
Visual function response to ocriplasmin for the treatment of vitreomacular traction and macular hole
31 January 2017
Paper of P95 co-author has been published online.
[…]
Read more…